Announcements

The Duke CTSA Research Career Development Award Program (Duke CTSA KL2) is now accepting applications.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

Monica Cfarku RN, MSN, BMTCN, CCM, NE-BC, has been named Assistant Vice President and Chief of Oncology Nursing Services for the Duke Cancer Institute.

NEW FROM DUKE HEALTH: Comprehensive virtual tour of Duke Health facilities, new med student/fellow/resident recruitment resources, and updated SoM facts & figures.

The Duke Cancer Center Durham and Duke Women’s Cancer Care Raleigh boutiques now open by appointment for in-person shopping, self-image consultations.

For a second year, Arif Kamal, MD, MHS, MBA, FAAHPM, FASCO, has been named an ASCO Advocacy Champion.

DCI medical oncologist Robin Hardie-Hood, MD, division chief of Medical Oncology at DRH, named medical director, Duke Cancer Center North Durham.

Duke Cancer Institute welcomes a new medical oncologist specializing in the treatment of breast cancer. He will practice at two of DCI's Wake County locations.

Join us with your “Don’t Ever Give Up!” spirit to ride any distance, any time and any place throughout August.

Duke Cancer Institute continues to ensure that patients have access to the safest and best-quality care possible.

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.

Radiation oncologist Joseph Kamel Salama, MD, named to the 2020 class of ASTRO Fellows.

From her family to yours: Duke ortho oncology surgeon Julia Visgauss, MD, invites one and all to this year's virtual event, to be held Sept. 12/13.

The Duke University SoM to expand into a newly-leased research center in RTP. Includes DHVI, CIVICS, Dept. of Surgery, Dept. of Medicine, Immunology, Pediatrics.

Nolan Miller, MHA, has been named administrative director, team lead, effective July 13. This is a newly created role within DCI.

Duke Cancer Institute welcomes a new clinical investigator specializing in bladder cancer to its Genitourinary Oncology program.

NCCN released new Guidelines for Patients in it's Immunotherapy Side Effects series, with the publication of a book focused on CAR T-Cell therapy.

A message from President Price and Chancellor Washington on Duke Becoming a Tobacco-Free Campus.

NCCN announced the publication of new Guidelines for Patients in the Immunotherapy Side Effects series with the publication of a book on Immune Checkpoint Inhibitors.

Flags were lowered to half-staff today across Duke for Neil Spector, MD, physician-scientist, mentor, advocate, friend, husband, and father who passed away on June 14.

 Yvonne Mowery, MD, PhD, was one of four young physician-scientists nationwide selected to receive the Damon Runyon Clinical Investigator Award.

On Monday, June 1, Caring House re-opened after having been closed temporarily due to COVID-19 precautions.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

This is of substantial significance to the department and university because it marks the funding of a new national center.

Twelve faculty in the School of Medicine were recently awarded distinguished professorships. A third of these are DCI members.

Duke Cancer Institute member and family physician Kevin Oeffinger, MD, has been named a Fellow of the American Society of Clinical Oncology (FASCO). 

The National Cancer Institute has created new pages on its website related to the rapidly evolving COVID-19 situation: one for patients and one for researchers.

Christopher Kelsey, MD, associate professor in the Department of Radiation Oncology and DCI member, was awarded the 2020 Algernon Sydney Sullivan Award.

The DCRI study is the first cardiovascular outcomes trial to compare two different types of cancer treatment.

The LLS COVID-19 Patient Financial Aid Program will provide $250 to eligible blood cancer patients experiencing financial hardship due to the pandemic.

PCORI has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus.

Duke Health research and clinical teams have confirmed a way to use existing vaporized hydrogen peroxide methods to decontaminate the masks.

The clinical trial of a potential COVID-19 therapy gives hospitalized adult patients with significant symptoms an option to participate.

Exec. director of DCI, Michael Kastan, MD, PhD, was one of 97 to sign an AACI letter imploring the president to use the DFA in the COVID-19 emergency.

Due to concern for the health and welfare of our patients and their families and friends, and in order to comply with official Duke policy, CRUSH to go virtual this year.

Graduate program rankings released today by U.S. News & World Report place the School of Nursing and School of Medicine among the top in the nation.

Lifetime Achievement Award Winner Keith Sullivan, MD, and colleagues reflect on his career and passion.

John Sampson, MD, PhD, MBA, named to new leadership role at Duke. Allan Friedman, MD, appointed interim chair of the Dept. of Neurosurgery.

Suzanne L. Topalian, MD, Sidney Kimmel Comprehensive Cancer Center, delivers the Thomas J. Matthews Endowed Lecture, March 11 via livestream.

Duke and Leica formally established a Leica Microsystems Center of Excellence at the Light Microscopy Shared Resource.

The Duke Department of Pathology/Duke Clinical Labs has established the Division of Artificial Intelligence and Computational Pathology.

Research on immunotherapy in NSCLC by Scott Antonia, MD, PhD, selected by ASCO for inclusion in Clinical Cancer Advances 2020.

An article co-authored by Meira Epplein, PhD, on H. pylori, published in the International Journal of Cancer, has been selected for a special IJC Virtual Issue.

Jennifer Wilkins, RN, MSN-HA, NEA-BC, admin. director, Duke Regional Hospital Based Clinics, elected president of the North Carolina Triangle Chapter of ONS.

Natalie Ashley, who began as a patient navigator with the DCBSM, has been instrumental in growing the program, say center leaders.

Medical oncologist Edwin P. Alyea, III, MD, formerly with Dana-Farber Cancer Institute, has been named chief medical officer (CMO) for Duke Cancer Institute.

Steven Bender, MBA, FHFMA, assumes his new role as senior director of finance, DCI, today, January 6.

Mark Oldham, PhD, has been named director of the Medical Physics Program, effective January 1, 2020.

Scott Floyd, MD, PhD, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate radiation director.